. , Signals that regulate dendritic cell maturation and functions

. , Regulation of human dendritic cell functions by natural IgG

J. Banchereau and R. M. Steinman, Dendritic cells and the control of immunity, Nature, vol.392, pp.245-52, 1998.

R. M. Steinman and J. Banchereau, Taking dendritic cells into medicine, Nature, vol.449, pp.419-445, 2007.

P. Guermonprez, J. Valladeau, L. Zitvogel, C. Thery, and S. Amigorena, Antigen presentation and T cell stimulation by dendritic cells, Annu Rev Immunol, vol.20, pp.621-67, 2002.

S. Akira, K. Takeda, and T. Kaisho, Toll-like receptors: critical proteins linking innate and acquired immunity, Nat Immunol, vol.2, pp.675-80, 2001.

A. Macagno, G. Napolitani, A. Lanzavecchia, and F. Sallusto, Duration, combination and timing: the signal integration model of dendritic cell activation, Trends Immunol, vol.28, pp.227-260, 2007.

H. K. Lee and A. Iwasaki, Innate control of adaptive immunity: dendritic cells and beyond, Semin Immunol, vol.19, pp.48-55, 2007.

N. Misra, J. Bayry, S. Lacroix-desmazes, M. D. Kazatchkine, and S. V. Kaveri, Cutting edge: human CD4+CD25+ Tcells restrain the maturation and antigen-presenting function of dendritic cells, J Immunol, vol.172, pp.4676-80, 2004.

Q. Tang, J. Y. Adams, and A. J. Tooley, Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice, Nat Immunol, vol.7, pp.83-92, 2006.

J. Bayry, F. Triebel, S. V. Kaveri, and D. F. Tough, Human dendritic cells acquire a semimature phenotype and lymph node homing potential through interaction with CD4+CD25+ regulatory T cells, J Immunol, vol.178, pp.4184-93, 2007.

R. Houot, I. Perrot, E. Garcia, I. Durand, and S. Lebecque, Human CD4+ CD25high regulatory T cells modulate myeloid but not plasmacytoid dendritic cells activation, J Immunol, vol.176, pp.5293-5301, 2006.

J. Bayry, S. V. Kaveri, and D. F. Tough, Do activated human dendritic cells diminish the suppressive functions of CD4+,CD25+ regulatory T cells? Comment on the article by van Amelsfort et al, Arthritis Rheum, vol.56, pp.3874-3880, 2007.

M. Veldhoen, H. Moncrieffe, R. J. Hocking, C. J. Atkins, and B. Stockinger, Modulation of dendritic cell function by naive and regulatory CD4+ T cells, J Immunol, vol.176, pp.6202-6212, 2006.

J. Bayry, D. R. Flower, D. F. Tough, and S. V. Kaveri, From 'perfect mix' to 'potion magique'-regulatory T cells and anti-inflammatory cytokines as adjuvant targets, Nat Rev Microbiol, vol.6, p.1, 2008.

J. Bayry, S. Lacroix-desmazes, S. Dasgupta, M. D. Kazatchkine, and S. V. Kaveri, Efficacy of regulatory T-cell immunotherapy: are inflammatory cytokines key determinants?, Nat Rev Immunol, vol.8, pp.1-86, 2008.

M. Miyara and S. Sakaguchi, Natural regulatory T cells: mechanisms of suppression, Trends Mol Med, vol.13, pp.108-124, 2007.

J. Bayry, S. Siberil, F. Triebel, D. F. Tough, and S. V. Kaveri, Rescuing CD4+CD25+ regulatory T-cell functions in rheumatoid arthritis by cytokine-targeted monoclonal antibody therapy, Drug Discov Today, vol.12, pp.548-52, 2007.

V. Moulin, F. Andris, K. Thielemans, C. Maliszewski, J. Urbain et al., B lymphocytes regulate dendritic cell (DC) function in vivo: increased interleukin 12 production by DCs from B celldeficient mice results in T helper cell type 1 deviation, J Exp Med, vol.192, pp.475-82, 2000.

C. Montagnoli, S. Bozza, and A. Bacci, A role for antibodies in the generation of memory antifungal immunity, Eur J Immunol, vol.33, pp.1193-204, 2003.

A. Kaser, S. Dunzendorfer, and F. A. Offner, B lymphocytederived IL-16 attracts dendritic cells and Th cells, J Immunol, vol.165, pp.2474-80, 2000.

P. Yu, Y. Wang, and R. K. Chin, B cells control the migration of a subset of dendritic cells into B cell follicles via CXC chemokine ligand 13 in a lymphotoxin-dependent fashion, J Immunol, vol.168, pp.5117-5140, 2002.

J. Bayry, S. Lacroix-desmazes, M. D. Kazatchkine, O. Hermine, D. F. Tough et al., Modulation of dendritic cell maturation and function by B lymphocytes, J Immunol, vol.175, pp.15-20, 2005.

A. Mizoguchi and A. K. Bhan, A case for regulatory B cells, J Immunol, vol.176, pp.705-715, 2006.

S. Avrameas, Natural autoantibodies: from 'horror autotoxicus' to 'gnothi seauton, Immunol Today, vol.12, pp.154-163, 1991.

K. Hayakawa, M. Asano, and S. A. Shinton, Positive selection of natural autoreactive B cells, Science, vol.285, pp.113-119, 1999.

K. Hayakawa, M. Asano, and S. A. Shinton, Positive selection of antithy-1 autoreactive B-1 cells and natural serum autoantibody production independent from bone marrow B cell development, J Exp Med, vol.197, pp.87-99, 2003.

A. Coutinho, M. D. Kazatchkine, and S. Avrameas, Natural autoantibodies, Curr Opin Immunol, vol.7, pp.812-820, 1995.

H. U. Lutz, Homeostatic roles of naturally occurring antibodies: an overview, J Autoimmun, vol.29, pp.287-94, 2007.

J. Bayry, O. Hermine, D. A. Webster, Y. Levy, and S. V. Kaveri, Common variable immunodeficiency: the immune system in chaos, Trends Mol Med, vol.11, pp.370-376, 2005.

M. Paroli, D. Accapezzato, and V. Francavilla, Long-lasting memory-resting and memory-effector CD4+ T cells in human Xlinked agammaglobulinemia, Blood, vol.99, pp.2131-2138, 2002.

J. Bayry, S. Lacroix-desmazes, and M. D. Kazatchkine, Common variable immunodeficiency is associated with defective functions of dendritic cells, Blood, vol.104, pp.2441-2444, 2004.

J. Bayry, S. Lacroix-desmazes, and V. Donkova-petrini, Natural antibodies sustain differentiation and maturation of human dendritic cells, Proc Natl Acad Sci U S A, vol.101, pp.14210-14215, 2004.

J. Bayry, S. Lacroix-desmazes, H. O. Oksenhendler, E. Kazatchkine, M. D. Kaveri et al., Amelioration of differentiation of dendritic cells from CVID patients by intravenous immunoglobulin, Am J Med, vol.118, pp.1439-1479, 2005.

J. Bayry, S. Lacroix-desmazes, M. D. Kazatchkine, and S. V. Kaveri, Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale and mechanisms of action, Nat Clin Pract Rheumatol, vol.3, pp.262-72, 2007.

R. Gold, M. Stangel, and M. C. Dalakas, Drug insight: the use of intravenous immunoglobulin in neurology-therapeutic considerations and practical issues, Nat Clin Pract Neurol, vol.3, pp.36-44, 2007.

Y. Sherer and Y. Shoenfeld, Mechanisms of disease: atherosclerosis in autoimmune diseases, Nat Clin Pract Rheumatol, vol.2, pp.99-106, 2006.

Y. Sherer and Y. Shoenfeld, Intravenous immunoglobulin for immunomodulation of systemic lupus erythematosus, Autoimmun Rev, vol.5, pp.153-158, 2006.

A. Amedei, C. Romagnani, and M. Benagiano, Preferential Th1 profile of T helper cell responses in X-linked (Bruton's) agammaglobulinemia, Eur J Immunol, vol.31, pp.1927-1961, 2001.

J. Bayry, M. D. Kazatchkine, and S. V. Kaveri, Shortage of human intravenous immunoglobulin-reasons and possible solutions, Nat Clin Pract Neurol, vol.3, pp.120-121, 2007.